These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37509566)

  • 1. Abnormal Expression of Prolyl Oligopeptidase (POP) and Its Catalytic Products Ac-SDKP Contributes to the Ovarian Fibrosis Change in Polycystic Ovary Syndrome (PCOS) Mice.
    Han S; Wang S; Fan X; Chen M; Wang X; Huang Y; Zhang H; Ma Y; Wang J; Zhang C
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal release of N-acetyl-seryl-aspartyl-lysyl-proline is part of an antifibrotic peptidergic system in the kidney.
    Romero CA; Kumar N; Nakagawa P; Worou ME; Liao TD; Peterson EL; Carretero OA
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F195-F203. PubMed ID: 30403163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase.
    Kumar N; Nakagawa P; Janic B; Romero CA; Worou ME; Monu SR; Peterson EL; Shaw J; Valeriote F; Ongeri EM; Niyitegeka JM; Rhaleb NE; Carretero OA
    Am J Physiol Renal Physiol; 2016 May; 310(10):F1026-34. PubMed ID: 26962108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetyl-seryl-aspartyl-lysyl-proline mediates the anti-fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice.
    Chan GCW; Wu HJ; Chan KW; Yiu WH; Zou A; Huang XR; Lan HY; Lai KN; Tang SCW
    Nephrology (Carlton); 2018 Apr; 23(4):297-307. PubMed ID: 28075040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Tβ4-POP-Ac-SDKP Axis in Organ Fibrosis.
    Wang W; Jia W; Zhang C
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP.
    Cavasin MA; Rhaleb NE; Yang XP; Carretero OA
    Hypertension; 2004 May; 43(5):1140-5. PubMed ID: 15037553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal inflammation and tubulointerstitial fibrosis in rats.
    Wang M; Liu R; Jia X; Mu S; Xie R
    Int J Mol Med; 2010 Dec; 26(6):795-801. PubMed ID: 21042772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New anti-fibrotic mechanisms of n-acetyl-seryl-aspartyl-lysyl-proline in silicon dioxide-induced silicosis.
    Sun Y; Yang F; Yan J; Li Q; Wei Z; Feng H; Wang R; Zhang L; Zhang X
    Life Sci; 2010 Aug; 87(7-8):232-9. PubMed ID: 20624403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Acetyl-seryl-aspartyl-lysyl-proline inhibits TGF-beta-mediated plasminogen activator inhibitor-1 expression via inhibition of Smad pathway in human mesangial cells.
    Kanasaki K; Koya D; Sugimoto T; Isono M; Kashiwagi A; Haneda M
    J Am Soc Nephrol; 2003 Apr; 14(4):863-72. PubMed ID: 12660320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.
    Castoldi G; di Gioia CR; Bombardi C; Perego C; Perego L; Mancini M; Leopizzi M; Corradi B; Perlini S; Zerbini G; Stella A
    Clin Sci (Lond); 2009 Oct; 118(3):211-20. PubMed ID: 20310083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension.
    Lin CX; Rhaleb NE; Yang XP; Liao TD; D'Ambrosio MA; Carretero OA
    Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1253-H1261. PubMed ID: 18641275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.
    Conte E; Iemmolo M; Fruciano M; Fagone E; Gili E; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S211-21. PubMed ID: 26098610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
    Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N
    J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the antifibrotic potential of N-acetyl seryl-aspartyl-lysyl-proline sequence peptides.
    Ramasamy V; Ntsekhe M; Sturrock E
    Clin Exp Pharmacol Physiol; 2021 Nov; 48(11):1558-1565. PubMed ID: 34347311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of Ac-SDKP on alveolar epithelial cells through inhibition of EMT via TGF-β1/ROCK1 pathway in silicosis in rat.
    Deng H; Xu H; Zhang X; Sun Y; Wang R; Brann D; Yang F
    Toxicol Appl Pharmacol; 2016 Mar; 294():1-10. PubMed ID: 26785300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased endogenous levels of Ac-SDKP promote organ fibrosis.
    Cavasin MA; Liao TD; Yang XP; Yang JJ; Carretero OA
    Hypertension; 2007 Jul; 50(1):130-6. PubMed ID: 17470726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner.
    Myöhänen TT; Tenorio-Laranga J; Jokinen B; Vázquez-Sánchez R; Moreno-Baylach MJ; García-Horsman JA; Männistö PT
    Br J Pharmacol; 2011 Aug; 163(8):1666-78. PubMed ID: 21133893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis.
    Zuo Y; Chun B; Potthoff SA; Kazi N; Brolin TJ; Orhan D; Yang HC; Ma LJ; Kon V; Myöhänen T; Rhaleb NE; Carretero OA; Fogo AB
    Kidney Int; 2013 Dec; 84(6):1166-75. PubMed ID: 23739235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylated α-Tubulin Regulated by N-Acetyl-Seryl-Aspartyl-Lysyl-Proline(Ac-SDKP) Exerts the Anti-fibrotic Effect in Rat Lung Fibrosis Induced by Silica.
    Xiaojun W; Yan L; Hong X; Xianghong Z; Shifeng L; Dingjie X; Xuemin G; Lijuan Z; Bonan Z; Zhongqiu W; Ruimin W; Brann D; Fang Y
    Sci Rep; 2016 Aug; 6():32257. PubMed ID: 27577858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts.
    Peng H; Carretero OA; Peterson EL; Rhaleb NE
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1357-64. PubMed ID: 20154264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.